Abstract: The present disclosure relates to a computer-implemented method for use in an electronic circuit design. Embodiments may include providing an electronic design having a plurality of geometric elements and generating a non-design element. Embodiments may further include associating the non-design element with one of the plurality of geometric elements and storing the non-design element with the one of the plurality of geometric elements. Embodiments may also include displaying, at a graphical user interface, the non-design element upon selection of the geometric element.

Abstract: The present disclosure relates to defining and processing hardware description language (HDL) groups. Embodiments may include mapping, using a processor, a set of tool-specific objects into a group graph with one or more groups. Embodiments may also include generating a search order associated with each group. The search order associated with each group may be based upon the hierarchical design configuration of the group graph. Embodiments may further include identifying undefined references from within a first group within the group graph and binding defined references from within the first group to electronic circuit design components. Embodiments may include identifying the undefined references from within a second group within the group graph. The second group may be selected based upon the undefined references and the search order associated with the first group.

Abstract: The invention relates to articles of manufacture of polyurethane-generating compositions for the manufacture of non-cytotoxic products for medical use, characterized in that these compositions contain: at least one polyisocyanate, preferably a non-aromatic polyisocyanate, in the monomer or prepolymer state; at least one polyol; and at least one dialkyl sulphoxide compound, preferably in the proportion of at least 2% by weight with respect to the total weight of the polyol or polyols.

Abstract: Medical article of manufacture comprising compositions, comprising: at least one polyisocyanate, preferably a non-aromatic polyisocyanate, in the monomer or prepolymer state; at least one polypol; and at least one organic compound comprising one or more phosphite functional groups, in the proportion of at least 1% by weight with respect to the total weight of the polyol or polyols, this organic compound being, in addition, non-aromatic and the carrier of at least one free hydroxyl group capable of reacting with an isocyanato group; and, if appropriate, at least one catalyst of the polymerization reaction of a polyisocyanate and of a polyol.